A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
Public ClinicalTrials.gov record NCT04269395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Multicenter, Long-term Follow-up Study to Assess Recurrence of Actinic Keratosis in Subjects Treated With Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) or Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT), for Subjects Achieving Complete Response of Treated Lesions at Final Visit in Study RD.06.SPR.112199
Study identification
- NCT ID
- NCT04269395
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 125 participants
Conditions and interventions
Conditions
Interventions
- MAL Cream Drug
- Vehicle cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2020
- Primary completion
- Aug 31, 2021
- Completion
- Aug 31, 2021
- Last update posted
- Oct 9, 2023
2020 – 2021
United States locations
- U.S. sites
- 52
- U.S. states
- 27
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site (Site#8447) | Fort Smith | Arkansas | 72916 | — |
| Galderma Investigational Site (Site#8577) | Encinitas | California | 92024 | — |
| Galderma Investigational Site (Site#8636) | Fountain Valley | California | 92708 | — |
| Galderma Investigational Site (Site#8224) | Fremont | California | 94538 | — |
| Galderma Investigational Site (Site#8778) | Denver | Colorado | 80210 | — |
| Galderma Investigational Site (Site#8440) | Greenwood Village | Colorado | 80111 | — |
| Galderma Investigational Site (Site#8479) | Bradenton | Florida | 34209 | — |
| Galderma Investigational Site (Site#8769) | Lake Worth | Florida | 33461 | — |
| Galderma Investigational Site (8770) | Lehigh Acres | Florida | 33936 | — |
| Galderma Investigational Site (Site#8765) | North Miami Beach | Florida | 33162 | — |
| Galderma Investigational Site (Site#8734) | Pembroke Pines | Florida | 33028 | — |
| Galderma Investigational Site (Site#8529) | Sanford | Florida | 32771 | — |
| Galderma Investigational Site (Site#8126) | West Palm Beach | Florida | 33401 | — |
| Galderma Investigational Site (Site#8667) | Columbus | Georgia | 31904 | — |
| Galderma Investigational Site (Site#8755) | Boise | Idaho | 83704 | — |
| Galderma Investigational Site | Boise | Idaho | 83713 | — |
| Galderma Investigational Site (Site#8838) | Darien | Illinois | 60561 | — |
| Galderma Investigational Site (Site#8724) | Louisville | Kentucky | 40241 | — |
| Galderma Investigational Site (Site#8208) | Beverly | Massachusetts | 01915 | — |
| Galderma Investigational Site (Site#8574) | Clarkston | Michigan | 48346 | — |
| Galderma Investigational Site (Site#8757) | Saint Joseph | Michigan | 49085 | — |
| Galderma Investigational Site | Edina | Minnesota | 55410 | — |
| Galderma Investigational Site | St Louis | Missouri | 63141 | — |
| Galderma Investigational Site (Site#8048) | Omaha | Nebraska | 68144 | — |
| Galderma Investigational Site 9Site#8420) | Portsmouth | New Hampshire | 03801 | — |
| Galderma Investigational Site (Site#8759) | Albuquerque | New Mexico | 87102 | — |
| Galderma Investigational Site | Brooklyn | New York | 11209 | — |
| Galderma Investigational Site | New York | New York | 10010 | — |
| Galderma Investigational Site | New York | New York | 10022 | — |
| Galderma Investigational Site | New York | New York | 10029-6501 | — |
| Galderma Investigational Site | New York | New York | 10075 | — |
| Galderma Investigational Site (Site#8566) | Charlotte | North Carolina | 28277 | — |
| Galderma Investigational Site (Site#8595) | Dublin | Ohio | 43016 | — |
| Galderma Investigational Site (Site#8212) | Portland | Oregon | 97210 | — |
| Galderma Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Galderma Investigational Site | Sugarloaf | Pennsylvania | 18249 | — |
| Galderma Investigational Site (Site#8777) | Charleston | South Carolina | 29407 | — |
| Galderma Investigational Site (Site#8207) | Nashville | Tennessee | 37215 | — |
| Galderma Investigational Site (Site#8076) | Austin | Texas | 78759 | — |
| Galderma Investigational Site (Site#8139) | College Station | Texas | 77845 | — |
| Galderma Investigational Site (Site#8664) | Frisco | Texas | 75034 | — |
| Galderma Investigational Site (Site#8576) | Houston | Texas | 77056 | — |
| Galderma Investigational Site (Site#8546) | Pflugerville | Texas | 78660 | — |
| Galderma Investigational Site (Site#8761) | Salt Lake City | Utah | 84101 | — |
| Galderma Investigational Site (Site#8672) | Salt Lake City | Utah | 84117 | — |
| Galderma Investigational Site (Site#8776) | St. George | Utah | 84790 | — |
| Galderma Investigational Site (Site#8057) | Lynchburg | Virginia | 24501 | — |
| Galderma Investigational Site (Site#8779) | Seattle | Washington | 98168 | — |
| Galderma Investigational Site (Site#8760) | Spokane | Washington | 99202 | — |
| Galderma Investigational Site 2(Site#8039) | Spokane | Washington | 99202 | — |
| Galderma Investigational Site (Site#8725) | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04269395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04269395 live on ClinicalTrials.gov.